Bispham Barbara Harlin Insider Trades & Stock Holdings

General Counsel and Corporate Secretary. · Crescent Biopharma, Inc. · Latest filing Sep 16, 2026

Bispham Barbara Harlin, General Counsel and Corporate Secretary. at Crescent Biopharma, Inc. has 2 Form 4 trades on file since Jun 22, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($33.01K), net -$33.01K. Latest filing: disposed of 620 shares of $CBIO on Sep 16, 2026 at $17.90.

Trades on file

2

Open-market bought

$0

Open-market sold

$33.01K

Net open-market

-$33.01K

Latest filing

Sep 16, 2026

All insider trades by Bispham Barbara Harlin

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 16, 2026	$CBIO	Sell (Open-market sale) 10b5-1	620	$17.90	$11.10K						General Counsel and Corporate Secretary.		—
Jun 22, 2026	$CBIO	Sell (Open-market sale) 10b5-1	1.22K	$17.99	$21.91K						General Counsel and Corporate Secretary.		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Bispham Barbara Harlin traded

• $CBIO

Frequently asked questions

Has Bispham Barbara Harlin been buying or selling stock?

Bispham Barbara Harlin has 0 open-market purchases and 2 open-market sales on file, net -$33.01K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Bispham Barbara Harlin's latest insider trade?

disposed of 620 shares of $CBIO on Sep 16, 2026 at $17.90.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.